Searched for
ANTI MALARIAL DRUGS
These large- and mid-cap stocks can give more than 25% return in 1 year, according to analystsThere are market phases when one risk dominates. Then there are phases like this, when risks arrive from every direction and refuse to stan...- These large- and mid-cap stocks may give more than 25% return in 1 year, according to analystsFor the last few earnings seasons, the message has been: “Show me growth, I have the money.” Stocks with better-than-expected earnings saw ...
- Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...
- Sun Pharma deal: Perception changer for Indian pharma sector? 10 pharma stocks with upside potential of up to 38%The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...
- Pakistan health authorities seek government permission to import mosquito nets from India after malaria cases surge due to floods: reportThe development came after a deadly malaria onslaught wreaked relentless havoc in flood-affected regions of the country, where hundreds of ...
- Government lifts export ban on anti-malarial drug hydroxychloroquine"The export policy of Hydroxychloroquine API (active pharmaceutical ingredients) and its formulations from prohibited to free with immediat...
- Enough stock of hydroxychloroquine in India: Govt"There is enough stock of hydroxychloroquine in the country and we are tracking its demand, availability and production on a daily basis," ...
- Trump seeks Modi's help to release Hydroxychloroquine ordered by US to treat COVID-19 patientsIndia on April 4 banned the export of Hydroxychloroquine and its formulations with immediate effect.
- COVID-19: Orders for over 10 crore anti-malarial hydroxychloroquine tablets placed by CentreThe Indian Council of Medical Research (ICMR) has recommended the anti-malarial drug for those involved in the care of suspected or confirm...
- US President touts anti-malarial drug as potential treatment for coronavirusAs the number of coronavirus cases in the US continued to rise, President Donald Trump on Thursday said that hydroxychloroquine, an anti-ma...
- Lincoln Pharma gets patent for anti-malarial drugThe company expects significant rise in the revenue from exports to Africa after the introduction of this injection in the African market.
- Effective malaria treatment a step closerThe discovery could potentially make malaria treatment significantly more effective for the 3.2 billion people at risk.
- Nutraplus starts production of Lumefantrine at Tarapur plantPharma firm Nutraplus India has started commercial production of anti-malarial drug Lumefantrine at its new plant at Tarapur in Maharashtra.
- Dr Datsons Labs to sell anti-malarial drugs in YemenDr Datsons Labs today said it has inked marketing and supply agreement with Yemen's Al-Mugdh Pharma to sell its anti-malarial drugs in Yemen
- Australian researchers find new drug to tackle malariaAustralian researchers said that a new drug that stops the malaria parasite from using vitamin B1 to multiply is now plausible.
- Strides gets WHO pre-qualification for anti-malarial tabletsDrug firm Strides Arcolab today said it has received World Health Organisation (WHO) pre- qualification for its anti-malarial tablets.
- Ranbaxy starts phase III study of anti-malaria drugRanbaxy Laboratories, India's largest drugmaker by sales, on Monday announced that its new anti-malarial combination drug is now undergoing...
- WHO agency, Ranbaxy part ways from drug developmentWHO agency Medicines for Malaria Venture and Ranbaxy were involved in a four year-long joint development programme for an anti-malarial com...
- Ranbaxy first Indian pharma to launch NCE globallyRanbaxy has completed the second phase of the clinical trial of a revolutionary anti- malarial drug.
- IPCA, CDRI to develop anti-malarial drugs based on ArtemisininIPCA Laboratories and Central Drug Research Institute (CDRI) will develop a synthetic substitute of anti-malarial drugs.
Load More
